CSIMC’s Committee to Assess Premium for New Drug Development Based on Results of Market Price Survey

At a meeting of the Central Social Insurance Medical Council’s (CSIMC; Chuikyo ) Expert Subcommittee on NHI Drug Pricing Affairs on September 28, the committee members recommended approval for documents indicating issues of the next NHI price system revision presented...read more